Organization
Toronto, Canada
5 abstracts
Abstract
Comprehensive whole genome and transcriptome analysis of patients with advanced solid tumor treated with immune checkpoint inhibitor therapy in the pan-cancer cohorts from the Marathon of Hope Cancer Centres Network Study (MOHCCN).Org: Princess Alexandra Hospital & University of Queensland, Woolloongabba, Australia, Toronto, Canada,
Abstract
Impact of pathogenic germline BRCA1/2 and PALB2 mutations and tumor aneuploidy in patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.Org: Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada, Toronto, ON, Canada,
Abstract
A VALIDATION OF CURRENT CLASSIFICATION CRITERIA FOR THE DIAGNOSIS OF PSORIATIC ARTHRITIS – PRELIMINARY RESULTS OF THE CASPAR STUDYOrg: Medicine and Frontier Science Center of Disease Molecular Network, Wellington School of Medicine, Wellington, New Zealand, Academic Unit of Musculoskeletal and Rehabilitation Medicine, University of Leeds,
Abstract
ANALYSIS AT ONE YEAR OF AN INCEPTION COHORT OF EARLY RHEUMATOID ARTHRITIS (RA): THE SONORA STUDYOrg: Cedars Sinai Medical Center, Los Angeles, United States, University Health Network, Toronto, Canada, New England Medical Center,
Abstract
B CELL DEPLETION FOR AUTOIMMUNE THROMBOCYTOPENIA AND AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUSOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Hematology Institute, SickKids Hospital, Toronto, Canada,